Overview

Prevention of Delirium in Inpatients Utilizing Melatonin

Status:
Terminated
Trial end date:
2017-11-03
Target enrollment:
Participant gender:
Summary
A double blind randomized controlled trial investigating melatonin, 5mg, compared to placebo, given to patients at least 65 years old, admitted to the hospital on a general medical floor, to prevent delirium.
Phase:
Phase 3
Details
Lead Sponsor:
Yale University
Treatments:
Melatonin